Regions Finl’s Earnings: A Preview

Regions Finl (NYSE:RF) is set to give its latest quarterly earnings report on Friday, 2023-04-21. Here’s what investors…

Regions Finl (NYSE:RF) is set to give its latest quarterly earnings report on Friday, 2023-04-21. Here’s what investors need to know before the announcement.

Analysts estimate that Regions Finl will report an earnings per share (EPS) of $0.66.

Regions Finl bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.02, which was followed by a 0.0% drop in the share price the next day.

Here’s a look at Regions Finl’s past performance and the resulting price change:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.65 0.57 0.53 0.47
EPS Actual 0.67 0.56 0.59 0.55
Price Change % 4.61% -0.96% 1.57% -0.86%

eps graph

Stock Performance

Shares of Regions Finl were trading at $19.22 as of April 19. Over the last 52-week period, shares are down 11.1%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Regions Finl visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Prelude Therapeutics Reports FY23 Financial Results And Outlines Key Objectives For 2024; FY23 EPS $(2.02) Vs $(2.44) YoY; Current Cash Runway Into 2026 With $232.9M In Cash, Cash Equivalents And Marketable Securities As Of December 31, 2023

First-in-class IV SMARCA2 degrader and potentially best-in-class CDK9 inhibitor on track to generate potential proof-of-concept data in 2024 Highly selective oral SMARCA2 degrader PRT7732 IND expected to be filed in

PRLD